Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • United Kingdom No evidence of young people moving from vape to tobacco…
  • Europe EC reveals environmental claims proposal…
  • United States FDA publishes list of tobacco-related petitions…
  • Cambodia Education minister tells schools to crack down on heated tobacco…
  • United Kingdom Ad breached the code by showing under-25s using heated tobacco…
  • Czech Republic Nicotine pouches come under tobacco regulations…
  • Maine - United States Possible ban on all flavoured tobacco products…
  • Taiwan Heated tobacco regulation and e-cig ban come into force…
  • United Kingdom ‘Smokefree 2030’ – government promises proposals soon…
  • United Kingdom Counterfeit cigarettes and other nicotine products seized…
  • Malta Petition calls for heated tobacco to be legalised…
  • Italy Ministers plan tax reform for tobacco and nicotine sales network…
View all
News analysis

Iqos 3 MRTP approval gets closer as US FDA starts substantive review

Written by || 14th May 2021 || News analysis | IQOS | North America United States

The US FDA considers that the Modified Risk Tobacco Product Application (MRTP) for Philip Morris International (PMI)’s Iqos 3 holder and charger is “sufficiently complete” to start a substantive review ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

PMTA and MRTP: navigating the path to FDA approval for reduced-risk products
US FDA grants modified risk orders to PMI’s Iqos and Marlboro HeatSticks
FDA gives the green light for IQOS roll-out onto the US market
© 2023
TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence,
does not accept any liability or responsibility for information or views published.